Hepatitis C and HIV Coinfection: The Why, Who, When, and How of Hepatitis C Therapy in 2014

Note: This is an archived resource. It is provided here for general reference, but users are advised to refer to other sources to confirm information. See full site Disclaimer.

title slide

Author: Cody A. Chastain, MD; Division of Infectious Diseases Vanderbilt University Medical Center


  1. Discuss the epidemiology, clinical impact, and risk factors for Hepatitis C (HCV) and HIV/HCV coinfection.
  2. Discuss the key issues when considering HCV therapy.
  3. Describe current and future HCV therapies as well as their side effects, efficacy, and drug-drug interactions.


Check all that apply
Check all that apply

Quick Survey

What percentage of your patients living with or at risk of HIV:

Add comment

Log in to post comments